Journal Scans
Long-Term Follow-Up of Autotransplantation Trials for Multiple Myeloma: Update of Protocols Conducted by the Intergroupe Francophone du Myelome, Southwest Oncology Group, and University of Arkansas for Medical Sciences
Long-Term Survival With Autotransplantation for Multiple Myeloma
B Barlogie, M Attal , J Crowley , F van Rhee, J Szymonifka, P Moreau, BG Durie, JL Harousseau
20100019
2010 Jan 19
J Clin Oncol
Long-Term Follow-Up of Autotransplantation Trials for Multiple Myeloma: Update of Protocols Conducted by the Intergroupe Francophone du Myelome, Southwest Oncology Group, and University of Arkansas for Medical Sciences
J Clin Oncol. 2010 Jan 19;Epub ahead of print, B Barlogie, M Attal , J Crowley , F van Rhee, J Szymonifka, P Moreau, BG Durie, JL Harousseau
TAKE-HOME MESSAGE
Abstract
SUMMARY
OncologySTAT Editorial Team
For patients with multiple myeloma, treatment with autotransplantation-supported high-dose melphalan therapy and novel agents has prolonged overall survival (OS). In addition, long-term results of a clinical trial with thalidomide showed significant improvement in OS, even though initial results from the study showed no apparent effect on survival. Barlogie et al. analyzed long-term follow-up data from 8 transplantation trials in patients with multiple myeloma, to evaluate long-term survival. In...
